Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
11-50
employees, estimated range
Grants
$2.9M
2 grants · CORDIS
Backers
2
General Catalyst, BGF
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 1, 2023 Won a grant $2.5M · CORDIS May 1, 2021 Won a grant $444k · CORDIS Apr 16, 2020 Founded per the company register
Funding rounds
RoundDateAmountInvestorsSource
Grant Apr 2023 $2.5M — CORDIS
Grant May 2021 $444k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity MAXION THERAPEUTICS LIMITED Companies House
Registered 16 Apr 2020
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Waracle15 roles
Waracle design and engineer digital products. Our people really care about your business. We collaborate to create digital product…
Recite Me7 roles
Recite Me is an Accessibility Software & Solutions provider - helping to create WCAG compliant websites and inclusive experiences online…
FROM CELLS TO ORGANELLES• ORGANELLES•. First-in-Class Isolated Organelles for Drug Discovery.
NYRA MedicalVenture round $12M · 3 yr ago • Founded 2018 • 11-50 employees
Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable…
PulseMedicaVenture round $12M · 2 yr ago • 51-200 employees • 2 roles
Learn about PulseMedica’s mission, story, and revolutionary technology for treating vitreoretinal disease. Mission. Vision. Co-Founders.
ITsavvyVenture round $81.4M · 4 yr ago • Founded 2022 • 201-500 employees
ITsavvy provides best-in-class IT solutions, so you can focus on what’s most mission-critical for your business. See the ITsavvy difference…

Visa sponsorship

  • United Kingdom · Licensed UK visa sponsor (Skilled Worker)

Visa details by country

Overview

Maxion Therapeutics | We are using our revolutionary KnotBody® technology to create first-in-class and best-in-class protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
London United Kingdom
HQ
10-50 est. staff

Financials

Total raised
$2.9M
Latest round
Grant
Funding rounds
2
Funding rounds
Round Announced Amount
Grant 2023 $2.5M Details
Grant 2021 $444k Details